Transvaginal Ultrasounds, Blood Tests Effective In Screening For Ovarian Cancer Among High-Risk Groups, Letter To Editor Says

Main Category: Ovarian Cancer
Also Included In: MRI / PET / Ultrasound;  Women's Health / Gynecology
Article Date: 27 Jun 2007 - 18:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Healthcare Prof:not yet rated


Although a blood test and a transvaginal ultrasound have "weak results" for "screening large unselected populations" for ovarian cancer, studies have shown "encouraging results" in detecting early-stage ovarian cancer in "high-risk" groups of women, Ilan Timor and John Curtin, professors of obstetrics and gynecology at New York University's School of Medicine, write in a New York Times letter to the editor in response to a June 19 Times editorial (Timor/Curtin, New York Times, 6/25).

The editorial said that the "real value" of recommendations from the American Cancer Society, Gynecologic Cancer Foundation and Society of Gynecologic Oncologists for identifying symptoms that could signal early stages of ovarian cancer might be to "raise awareness" of the disease among physicians and their patients. The groups are calling on women who experience the symptoms -- which include bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, and a frequent or urgent need to urinate -- every day for two to three weeks to see a gynecologist. The recommendations are expected to be formally announced on June 25. According to the editorial, a blood test and a transvaginal ultrasound are "notoriously inaccurate," and many women still might "opt for surgery to remove the ovary, just to be sure" (Kaiser Daily Women's Health Policy Report, 6/19).

Timor and Curtin write that the tests are not "notoriously inaccurate," adding that a transvaginal ultrasound has an "undisputed" diagnostic value. According to the authors, "In the setting of a symptomatic patient, where the diagnosis of ovarian cancer is a possibility, transvaginal ultrasound is probably the most appropriate test" (New York Times, 6/25).

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our ovarian cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
n.p. "Transvaginal Ultrasounds, Blood Tests Effective In Screening For Ovarian Cancer Among High-Risk Groups, Letter To Editor Says." Medical News Today. MediLexicon, Intl., 27 Jun. 2007. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/75192.php>

APA
n.p. (2007, June 27). "Transvaginal Ultrasounds, Blood Tests Effective In Screening For Ovarian Cancer Among High-Risk Groups, Letter To Editor Says." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/75192.php.

Please note: If no author information is provided, the source is cited instead.


Ovarian Cancer

Most Popular Articles



Follow Our Ovarian Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Ovarian Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »